colorectal-cancer

Documents about colorectal-cancer

• Lineage plasticity driven by GATA6 loss fuels colorectal cancer metastasis.#483416NCBI PubMed Central
• Meat and colorectal cancer: Gut microbiota may play a major role#643334HAL (France)
• Colorectal cancer chemoprevention: is aspirin still in the game?#670105HAL (France)
• Readmission and Dehydration Prevention in Patients With Elective Ileostomy#825195ClinicalTrials.gov
• Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI#831909ClinicalTrials.gov
• Investigating the impact of macrophages and hypoxia on cell plasticity in colorectal cancer#287790Figshare
• Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy#442077ClinicalTrials.gov
• A Retrospective Review of Malignant Liver Tumors#807480ClinicalTrials.gov
• A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer#195518ClinicalTrials.gov
• Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne® Liquid CDx#315023HAL (France)
• Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer#804796ClinicalTrials.gov
• Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer#201763ClinicalTrials.gov
• Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors#245375ClinicalTrials.gov
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer#804129ClinicalTrials.gov
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors#195313ClinicalTrials.gov
• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands#208441ClinicalTrials.gov
• Table 2_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.xlsx#249977Figshare
• Table 1_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.xlsx#249978Figshare
• Image 1_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.tif#249979Figshare
• Table 3_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.xlsx#249980Figshare
• Image 3_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.tif#249981Figshare
• Image 2_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.tif#249982Figshare
• Image 5_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.tif#249983Figshare
• Image 4_Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer.tif#249984Figshare
• Modeling Vulnerability of KRAS and BRAF mutant Colorectal Cancer towards Interference with DNA Damage Response#261743edoc-Server
• A Role for the Circadian Clock in Colorectal Cancer Progression: A Comprehensive Molecular Analysis on the Interplay between Core-Clock Genes and Metastasis-related Cellular Processes#261746edoc-Server
• Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer#321692ClinicalTrials.gov
• Navigating long-term patient-reported outcomes after colorectal cancer surgery in older adults: ostomy, nutritional status, and living conditions as determinants in a prospective cohort study#345338OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• The Allium cepa Derived Compound Propyl Propane Thiosulfonate (PTSO) Improves Tumorigenesis Due to Its Immunomodulatory Effect: A Preclinical Study#446863Repositorio Institucional de la Universidad de Granada
• The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.#830248ClinicalTrials.gov
• A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer#825749ClinicalTrials.gov
• Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure#18785ClinicalTrials.gov
• Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC#158198ClinicalTrials.gov
• Validation of the fear of cancer recurrence inventory-short form in long-term colorectal cancer survivors.#354918NCBI PubMed Central
• Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer#390906ClinicalTrials.gov
• Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial#804305ClinicalTrials.gov
• Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone#830013ClinicalTrials.gov
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies#180380ClinicalTrials.gov
• Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer#807795ClinicalTrials.gov
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies#417550ClinicalTrials.gov
• Genetic Risk: Whether, When, and How to Tell Adolescents#805574ClinicalTrials.gov
• Social and geographical factors influencing the delay in treatment for colorectal cancer#126759HAL (France)
• Natural essential oils as a new therapeutic tool in colorectal cancer#260626Repositorio USS
• Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment#326312HAL (France)
• Identifying metabolomic mediators of the physical activity and colorectal cancer relationship#345872Spiral
• Regulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness#347811HAL (France)
• Cellular reprogramming and signaling control by kaempferol in colorectal cancer.#449862NCBI PubMed Central
• PTEN status, tumor immune microenvironment, and survival in colorectal cancer.#461528NCBI PubMed Central
• Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project#800570ClinicalTrials.gov
• The 3V score and joint associations of low ultra-processed food, biodiverse and plant-based diets on colorectal cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study#218023HAL (France)